ArticleACS pharmacology & translational science2023

Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.